OasisLMS

This neurosurgical topic session was recorded live at the 2025 AANS Annual Scientific Meeting.

This session will be presented by leaders with experience in creating prominent fellowships and will outline establishing and managing fellowship programs. There will be representatives from CAST and other accrediting bodies to provide a well-rounded view of the fellowship creation process. The comprehensive session aims to cover multiple subspecialties, including cranial, vascular, tumor and endovascular.

Speakers: Perry Ball, Charles Branch, Charles Branch, Richard Ellenbogen, William Mack, Jonathan Miller, Michael Steinmetz, Vincent Traynelis

The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AANS designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The last date to claim credit is 06/26/2027.

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the AANS must ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Education, the AANS is required to disclose to the activity audience the relevant financial relationships of the planners, faculty and any other individual in a position to control content of this activity.

Those who have disclosed a relationship with ineligible companies are listed below.

All disclosed financial relationships have been mitigated in accordance with ACCME standards.

Name	Relationship/Company
Charles Branch	Medtronic: Consultant (Ongoing), Royalty Recipient (Ongoing)
William Mack	Borvo Medical, Inc.: Stock Options (Ongoing); Cerebrotech: Stock Options (Terminated); Egret Therapeutics: Stock Options (Ongoing); Endostream: Stock Options (Ongoing); Imperative Care: Consultant (Ongoing); Kaneka: Consultant (Ongoing); Medtronic: Consultant (Ongoing); Q'Apel: Stock Options (Ongoing); Radical Catheter Technologies, Inc.: Stock Options (Ongoing); Spartan Micro: Stock Options (Ongoing); Stream Biomedical: Stock Options (Ongoing); Stryker: Consultant (Ongoing); Vastrax: Stock Options (Ongoing); Viseon: Stock Options (Ongoing)
Michael Steinmetz	Cerapeadics: Speaker/Honoraria (Ongoing); Elsevier, Inc.: Royalty Recipient (Ongoing); Globus: Royalty Recipient (Ongoing), Speaker/Honoraria (Ongoing); Premia Spine: Speaker/Honoraria (Terminated, December 3, 2024)
Vincent Traynelis	NuVasive/Globus: Royalty Recipient (Ongoing)

Planners, faculty and any other individuals in control of content not listed have indicated that they have no relevant financial relationships or conflict of interest to disclose for this activity.